Fund shareholders of MIRA PHARMACEUTICALS INC
ISIN US60458C1045 · United States · LEI 5493000N6HPDY7V7OR15
- Fund shareholders
- 6
- Of which ETFs
- 0 6 other funds
- Value held
- 1M $
- Share of capital
- 2.2 % of 42M shares on Aug 10, 2026
| Fund | Shares | Value | Weight in fund | Share of capital | |
|---|---|---|---|---|---|
| VANGUARD EXTENDED MARKET INDEX FUND VANGUARD INDEX FUNDS | 356,689 | 381.7K $ | 0.00 % | 0.85 % | as of Mar 31, 2026 ↗ |
| VANGUARD TOTAL STOCK MARKET INDEX FUND VANGUARD INDEX FUNDS | 337,223 | 360.8K $ | 0.80 % | as of Mar 31, 2026 ↗ | |
| Fidelity Extended Market Index Fund Fidelity Concord Street Trust | 158,268 | 201K $ | 0.00 % | 0.38 % | as of Feb 28, 2026 ↗ |
| Fidelity Series Total Market Index Fund Fidelity Concord Street Trust | 38,017 | 48.3K $ | 0.09 % | as of Feb 28, 2026 ↗ | |
| Fidelity Total Market Index Fund Fidelity Concord Street Trust | 35,895 | 45.6K $ | 0.09 % | as of Feb 28, 2026 ↗ | |
| Fidelity Nasdaq Composite Index Fund Fidelity Concord Street Trust | 9,455 | 12K $ | 0.00 % | 0.02 % | as of Feb 28, 2026 ↗ |
The funds most exposed to it
The weight is the share of a fund's net assets. The holders table ranks funds by number of shares. This one ranks them by the weight of the company in each fund.
| Fund | Weight in fund | |
|---|---|---|
| Fidelity Extended Market Index Fund Fidelity Concord Street Trust | 0.00 % | as of Feb 28, 2026 ↗ |
| VANGUARD EXTENDED MARKET INDEX FUND VANGUARD INDEX FUNDS | 0.00 % | as of Mar 31, 2026 ↗ |
| Fidelity Nasdaq Composite Index Fund Fidelity Concord Street Trust | 0.00 % | as of Feb 28, 2026 ↗ |
Quarter after quarter
Each row is one quarter of SEC filings, newest first. The change compares each quarter with the one before.
| Quarter | Shareholders | Change | Shares | Change |
|---|---|---|---|---|
| 2026Q2 | 6 | -1 | 935,547 | +61.1 % |
| 2026Q1 | 7 | +1 | 580,622 | +141.6 % |
| 2025Q4 | 6 | +1 | 240,299 | +2.8 % |
| 2025Q3 | 5 | 0 | 233,657 | +5.4 % |
| 2025Q2 | 5 | 0 | 221,786 | -0.8 % |
| 2025Q1 | 5 | +4 | 223,526 | +2,264.1 % |
| 2024Q4 | 1 | 0 | 9,455 | 0.0 % |
| 2024Q3 | 1 | 0 | 9,455 | 0.0 % |
| 2024Q2 | 1 | 0 | 9,455 | 0.0 % |
| 2024Q1 | 1 | 9,455 |
Institutional managers
23 managers declare this company to the SEC (Form 13F).
| Manager | Shares | Value | |
|---|---|---|---|
| Cross Staff Investments Inc | 359,401 | 384.6K $ | as of Mar 31, 2026 |
| GEODE CAPITAL MANAGEMENT, LLC | 290,890 | 311.3K $ | as of Mar 31, 2026 |
| BlackRock, Inc. | 112,346 | 120.2K $ | as of Mar 31, 2026 |
| Suncoast Equity Management | 90,645 | 97K $ | as of Mar 31, 2026 |
| NORTHERN TRUST CORP | 67,698 | 72.4K $ | as of Mar 31, 2026 |
| FIRST AMERICAN BANK | 60,000 | 64.2K $ | as of Mar 31, 2026 |
| STATE STREET CORP | 49,100 | 52.5K $ | as of Mar 31, 2026 |
| XTX Topco Ltd | 37,573 | 40.2K $ | as of Mar 31, 2026 |
| COMMONWEALTH EQUITY SERVICES, LLC | 35,067 | 37.5K $ | as of Mar 31, 2026 |
| INTERNATIONAL ASSETS INVESTMENT MANAGEMENT, LLC | 35,000 | 37.1K $ | as of Mar 31, 2026 |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 25,146 | 26.9K $ | as of Mar 31, 2026 |
| Frec Markets, Inc. | 22,000 | 23.5K $ | as of Mar 31, 2026 |
| FIFTH THIRD BANCORP | 20,000 | 21.4K $ | as of Mar 31, 2026 |
| Mariner, LLC | 16,500 | 17.7K $ | as of Mar 31, 2026 |
| CARY STREET PARTNERS FINANCIAL LLC | 10,000 | 10.7K $ | as of Mar 31, 2026 |
| Federation des caisses Desjardins du Quebec | 8,000 | 8.6K $ | as of Mar 31, 2026 |
| UBS Group AG | 6,456 | 6.9K $ | as of Mar 31, 2026 |
| Tower Research Capital LLC (TRC) | 4,976 | 5.3K $ | as of Mar 31, 2026 |
| CITIGROUP INC | 4,226 | 4.5K $ | as of Mar 31, 2026 |
| OSAIC HOLDINGS, INC. | 2,000 | 2.1K $ | as of Mar 31, 2026 |
| Steward Partners Investment Advisory, LLC | 2,000 | 2.1K $ | as of Mar 31, 2026 |
| WELLS FARGO & COMPANY/MN | 23 | 25 $ | as of Mar 31, 2026 |
| Caitong International Asset Management Co., Ltd | 1 | 1 $ | as of Mar 31, 2026 |
Cite this page
Titelia. "Fund shareholders of MIRA PHARMACEUTICALS INC". https://titelia.com/en/stocks/mira-pharmaceuticals-inc-US60458C1045